학술논문

Low plasma estradiol, low expression of estrogen responsive genes and TP53 mutations are associated with poor anti-proliferative response to aromatase inhibitors
Document Type
Journal
Source
CANCER RESEARCH; MAR 1 2023, 83 5, 3p. Supplement: S
Subject
Language
English
ISSN
15387445